8 newsletters, ranked by editorial quality and how recently they published. Looking for something more specific? Search instead.
Roger Pielke Jr. writes about science, policy and politics, with a focus on climate, extreme weather, disaster losses and energy. Readers get data-driven analysis and first-person accounts of his talks and research.
A practicing data scientist and tenured professor writes weekly essays on AI, genomics, biosecurity, and how AI is changing science, with occasional programming notes. Readers get candid, first-hand takes on research evaluation, AI disclosure policies in journals, and commentary on new biosecurity literature.
Macroscience is a newsletter about improving how science is funded, organized and evaluated, with a focus on metascience, research institutions and science policy. Readers get analysis of government metascience initiatives, debates between policy experts, and commentary from economists on how AI may reshape scientific progress.
A science-policy newsletter examining how US biomedical funding and research practice could be improved, including proposals for reporting null results and critiques of NIH oversight. Readers get analysis of agency processes, metascience ideas and guest perspectives from former officials.
A newsletter by Saloni Dattani on medical progress, scientific innovation and how to communicate data well. Readers get long-form, carefully sourced essays that put medical breakthroughs and science funding in historical context, plus practical guidance on data visualization.
Free The Inquiry is Heterodox Academy's publication of essays, expert commentary and conversations on open inquiry and free debate in universities. Recent issues cover AI disruption of academic research, political polarization in higher education, and a debate between a philosopher and a biologist on the ethics of editing human embryos.
A Substack publication featuring data analyses and guest essays that challenge mainstream narratives on transgender identification, gender medicine, sports science and media coverage of politicized research. Readers get argument-driven pieces, often by credentialed academics and clinicians, with some links to SEGM research.
A genomics PhD writes pro-progress commentary arguing against safetyist framings of AI, nuclear power and data centers, and that regulation and clinical trials are the real bottlenecks rather than intelligence. Readers get a contrarian, optimistic take on AI policy and abundance-minded science debates.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
